Clinical Trials Browser

Phase 2 × remetinostat × Dermatologic × Clear all

NCT03180528 2021-06-08

Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer

Phase 2 Completed

30 enrolled 10 charts

Carcinoma, Basal Cell